Eliem Therapeutics Inc. (ELYM)
NASDAQ: ELYM
· Real-Time Price · USD
5.11
-0.05 (-0.97%)
At close: Oct 02, 2024, 8:00 PM
Eliem Therapeutics Revenue
Eliem Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2024, Eliem Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
9
Market Cap
342.68M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|